Avantax Advisory Services Inc. boosted its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 147.0% in the 3rd quarter, HoldingsChannel reports. The fund owned 34,794 shares of the healthcare conglomerate’s stock after acquiring an additional 20,708 shares during the period. Avantax Advisory Services Inc.’s holdings in UnitedHealth Group were worth $10,849,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. State Street Corp boosted its holdings in shares of UnitedHealth Group by 0.5% in the 1st quarter. State Street Corp now owns 46,003,796 shares of the healthcare conglomerate’s stock valued at $11,472,427,000 after buying an additional 212,240 shares in the last quarter. Skandinaviska Enskilda Banken AB publ boosted its holdings in shares of UnitedHealth Group by 22.6% in the 1st quarter. Skandinaviska Enskilda Banken AB publ now owns 484,187 shares of the healthcare conglomerate’s stock valued at $120,747,000 after buying an additional 89,211 shares in the last quarter. Silvercrest Asset Management Group LLC boosted its holdings in shares of UnitedHealth Group by 7.8% in the 1st quarter. Silvercrest Asset Management Group LLC now owns 10,135 shares of the healthcare conglomerate’s stock valued at $2,527,000 after buying an additional 734 shares in the last quarter. Driehaus Capital Management LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at $209,000. Finally, Balyasny Asset Management LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at $3,636,000. Institutional investors own 86.39% of the company’s stock.

Several research analysts have recently issued reports on the stock. Bank of America upped their target price on shares of UnitedHealth Group from $351.00 to $365.00 and gave the company a “buy” rating in a report on Friday, August 28th. Jefferies Financial Group upped their price target on shares of UnitedHealth Group from $310.00 to $335.00 and gave the company a “hold” rating in a research report on Thursday. SVB Leerink upped their price target on shares of UnitedHealth Group from $370.00 to $373.00 and gave the company an “outperform” rating in a research report on Thursday. Raymond James upped their price target on shares of UnitedHealth Group from $350.00 to $355.00 and gave the company a “strong-buy” rating in a research report on Thursday. Finally, Credit Suisse Group set a $335.00 price target on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Wednesday. Four equities research analysts have rated the stock with a hold rating, twenty-one have given a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $346.68.

In related news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $320.59, for a total value of $4,808,850.00. Following the sale, the director now directly owns 159,215 shares of the company’s stock, valued at approximately $51,042,736.85. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Marianne D. Short sold 10,336 shares of the stock in a transaction dated Friday, August 28th. The shares were sold at an average price of $312.34, for a total transaction of $3,228,346.24. Over the last ninety days, insiders have sold 47,336 shares of company stock worth $14,928,276. Corporate insiders own 0.80% of the company’s stock.

NYSE:UNH opened at $329.90 on Friday. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 0.60. UnitedHealth Group Inc has a fifty-two week low of $187.72 and a fifty-two week high of $333.70. The stock has a market cap of $313.52 billion, a PE ratio of 18.55, a price-to-earnings-growth ratio of 1.44 and a beta of 0.68. The firm’s fifty day simple moving average is $311.35 and its 200-day simple moving average is $297.69.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.98 by $0.53. UnitedHealth Group had a net margin of 6.90% and a return on equity of 29.28%. The business had revenue of $65.12 billion for the quarter, compared to analysts’ expectations of $63.97 billion. During the same period in the prior year, the company posted $3.88 EPS. The business’s revenue for the quarter was up 7.9% on a year-over-year basis. Equities analysts anticipate that UnitedHealth Group Inc will post 16.58 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were paid a dividend of $1.25 per share. The ex-dividend date was Friday, September 11th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.09%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: What is the price-to-earnings growth (PEG) ratio?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.